Ana Pedrero Gil: Navigating Anemia Management in Patients With Stroke or Malignancy History
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn, about a recent article by Rammdeep Saini, published in Canadian Journal of Kidney Health and Disease, adding:
“Erythropoiesis-stimulating agents (ESAs) are commonly used to manage chronic kidney disease (CKD) associated anemia.
There is a paucity of clear guidelines on their use in patients with CKD and with history of stroke or malignancy.”
Title: A Canadian Survey of Prescribing Practices of Erythropoiesis-Stimulating Agents in Dialysis-Dependent and Non-Dialysis-Dependent Chronic Kidney Disease
Authors: Rammdeep Saini, Keigan More, Jo-Anne S. Wilson, David A. Clark, Amanda J. Vinson, David Collister, Mark Canney, and Karthik K. Tennankore
Stay updated on all scientific advances with Hemostasis Today.
-
May 14, 2026, 15:00Snehal Gis: Gene Therapy Revolutionizing the Hemophilia Treatment Landscape
-
May 14, 2026, 14:43Sharon Bukola Afolabi: Why Standing Up Is a Bigger Workout for Your Heart Than You Think
-
May 14, 2026, 14:37Grigoris Gerotziafas: Join Our Workshop on Advancing Guideline Adoption in Cancer-Associated Thrombosis at ISTH 2026
-
May 14, 2026, 14:31Jonathan Douxfils: A Critical Review of NETosis Measurement Methods and the Need for Standardization
-
May 14, 2026, 14:21Mavis Agnes Kisakye: With Pride and Gratitude Haemophilia Foundation of Uganda Accepts the Project of the Year 2026 Award
-
May 14, 2026, 14:14Aikati Anastasiou: Blood Pressure Variability in Rescue Stenting for Acute Ischaemic Stroke
-
May 14, 2026, 14:00Amro Al-Manasrah: Coronary Reperfusion Injury Beyond Large-Vessel Occlusion
-
May 14, 2026, 13:54Abdul Mannan: The Dual Biology of the Sickle Cell Mutation
-
May 14, 2026, 13:54Pauline Nerwande: Hemostasis and the Balance Between Bleeding and Thrombosis